foxo4 dri human trial senolytic Buy FOXO4-DRI 10mg | Third-Party Tested FOXO4-DRI 10mg vial - Description
FOXO4 DRI 10mg vial Description RCpeptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK
Pay in 4 interest-free payments of $6.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



